Insider · CIK 0001591411

Sanford Svai S

Reports to the SEC for 2 companies · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001591411

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-23	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+325K sh	—	—	325,000
2024-03-21	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+324K sh	—	—	323,500
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−172K sh	—	—	34,300
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+172K sh	—	—	171,500
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−58.3K sh	—	—	41,666
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+58.3K sh	—	—	58,334
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−83.7K sh	—	—	127,788
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+83.7K sh	—	—	83,724
2023-03-27	RANIRani Therapeutics Holdings, Inc.A Award	Chief Financial Officer	AAward	+139K sh	—	—	258,597
2023-03-27	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+206K sh	—	—	205,800
2023-03-22	RANIRani Therapeutics Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,355 sh	$5.95	−$20K	119,597
2022-09-09	RANIRani Therapeutics Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−18.4K sh	$9.89	−$182K	120,738
2022-03-22	RANIRani Therapeutics Holdings, Inc.A Award	Chief Financial Officer	AAward	+32.9K sh	—	—	139,100
2022-03-22	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2021-09-09	RANIRani Therapeutics Holdings, Inc.A Award	Chief Financial Officer	AAward	+106K sh	—	—	106,200
2015-08-03	VIVUS INCA Award	Chief Financial Officer	AAward	+62.8K sh	—	—	128,359
2015-01-29	VIVUS INCS Sale	Chief Financial Officer	SSale	−472 sh	$2.78	−$1,312.16	65,559
2015-01-23	VIVUS INCA Award	Chief Financial Officer	AAward	+25.3K sh	—	—	66,031
2015-01-23	VIVUS INCEmployee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+240K sh	—	—	240,300
2014-01-28	VIVUS INCA Award	Chief Financial Officer	AAward	+4,200 sh	—	—	37,849
2014-01-28	VIVUS INCEmployee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+38.3K sh	—	—	38,300
2014-01-22	VIVUS INCA Award	Chief Financial Officer	AAward	+30K sh	—	—	33,649

Recent filings

Accepted (ET)
May 234
Sanford Svai S0000950170-25-077180
SEC(opens sec.gov)
Mar 224
Sanford Svai S0000950170-24-035570
SEC(opens sec.gov)
Dec 194
Sanford Svai S0000950170-23-071474
SEC(opens sec.gov)
Mar 294
Sanford Svai S0001415889-23-005596
SEC(opens sec.gov)
Mar 244
Sanford Svai S0000899243-23-009587
SEC(opens sec.gov)
Sep 134
Sanford Svai S0001209191-22-049802
SEC(opens sec.gov)
Mar 244
Sanford Svai S0001209191-22-021021
SEC(opens sec.gov)
Sep 134
Sanford Svai S0001209191-21-055777
SEC(opens sec.gov)
Aug 54
VIVUS INC0001123292-15-001061
SEC(opens sec.gov)
Jan 304
VIVUS INC0001104659-15-005690
SEC(opens sec.gov)
Jan 274
VIVUS INC0001104659-15-004780
SEC(opens sec.gov)
Jan 304
VIVUS INC0001104659-14-005317
SEC(opens sec.gov)

Companies

Address

C/O VIVUS, INC. 351 EAST EVELYN AVENUE

MOUNTAIN VIEW, CA, 94041